Last updated: May 15, 2017
Sponsor: Novartis
Overall Status: Completed
Phase
4
Condition
Dyslipidemia
Treatment
N/AClinical Study ID
NCT00125125
CXUO320B2406
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Dyslipidemia
History of Myalgia
Exclusion
Exclusion Criteria:
Previous treatment with fluvastatin
Age < 18 years Other protocol-defined inclusion and exclusion criteria may apply.
Study Design
Total Participants: 218
Study Start date:
May 01, 2005
Estimated Completion Date:
December 31, 2005
Connect with a study center
Investigative Centers,
GermanySite Not Available
Novartis
East Hanover, New Jersey 07936
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.